Drugs and drug administration in extreme environments

Journal of Travel Medicine

Volumn 13, Issue 1, 2006, Pages 35-47

  Küpper, Thomas E A H ^a,b,f   Bettina, Schraut ^b   Burkhard, Rieke ^b   Hemmerling, Arnica Verena ^c   Volker, Schöffl ^d   Juergen, Steffgen ^e  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Center for Travel Medicine   (Germany)

^c Krankenhaus Benrath   (Germany)

^d KLINIKUM BAMBERG   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADRENALIN; AJMALINE; ALTEPLASE; AMIODARONE; ATROPINE; CAFEDRINE; CHLORAL HYDRATE; CLEMASTINE; CLONIDINE; DEXTRAN; DIGOXIN; DIHYDRALAZINE; DOBUTAMINE; DOPAMINE; ETILEFRINE; GLYCERYL TRINITRATE; INSULIN; LIDOCAINE; METOPROLOL; NALOXONE; NIFEDIPINE; NORADRENALIN; ORCIPRENALINE; PINDOLOL; POLYGELINE; THEODRENALINE; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL;

ARCTIC; ARMY; DRUG ADMINISTRATION; DRUG SAFETY; DRUG STABILITY; EMERGENCY MEDICINE; ENVIRONMENTAL TEMPERATURE; FREEZING; MEDICAL PERSONNEL; REVIEW; TOURISM; TRAVEL; TROPICS;

CLIMATE; DRUG ADMINISTRATION ROUTES; DRUG LABELING; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; EMERGENCY MEDICAL SERVICES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; TEMPERATURE; TROPICAL CLIMATE; WORLD HEALTH;

EID: 33645317050     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00007.x     Document Type: Review

References (57)

1. Küpper T Steffgen J Jansing P. Cold exposure during helicopter rescue operations in the Western Alps. Ann Occup Hyg 2003 47 7 16.
2. Becker G Fritz HE Mennicke W et al. Temperaturbelastung von Arzneimitteln an Bord. Pharm Ztg 1983 128 794 797.
3. Rudland SV Jacobs AG. Visiting bags: a labile thermal environment. BMJ 1994 308 954 956.
4. Stability testing guidelines - stability testing of new drug substances and products (step 5 London European Agency for the Evaluation of Medical Products 1998.
5. Declaration of storage conditions for medical products in the products particulars. London European Agency for the Evaluation of Medical Products 1998.
6. Stability testing for Type II variation to a marketing authorization. London European Agency for the Evaluation of Medical Products 1998.
7. Johansen RB Schafer NC Brown PI. Effect of extreme temperatures on drugs for prehospital ACLS. Am J Emerg Med 1993 11 450 452.
8. Hogerzeil HV Battersby A Srdanovic V Stjernstrom NE. Stability of essential drugs during shipment to the tropics. BMJ 1992 304 210 212.
9. Castner T. Temperaturbelastung von Medikamenten in der präklinischen Notfallmedizin. Ulm, Germany Department of Anaesthesiology and Intensive Care, University of Ulm 2000.
10. Grant TA Caroll RG Castner T. Environmental temperature variations cause degradations in epinephrine concentration and biological activity. Am J Emerg Med 1994 12 319 322.
11. Schüttler J Strauss H. Haltbarkeit von Notfallmedikamenten im Notfallkoffer. Notfall Rettungsmed 2000 2 101 102.
12. Speer G. Criss EA, Hammargren WM, Haltbarkeit, Verfall und Austausch von Notfallmedikamenten. Notarzt 1993 9 173 178.
13. Bernhard R. Lagerung von Notfallmedikamenten im Rettungs- und Notarztwagen. In Sefrin P ed. Klinische und experimentelle Notfallmedizin. München, Bern, Wien Zuckerschwerdt Verlag 1990 17 24.
14. Forth W Henschler D Rummel W. Allgemeine und spezielle Pharmakologie und Toxikologie [General and special pharmacology and toxicology]. 8th Aufl. Ed. München Urban & Fischer Verlag 2001.
15. Goodman Gilman A. Goodman & Gilman's: the pharmacological basis of therapeutics. In Hardman JG Limbird LE Gilman GA eds. 10th Ed. New York Mc Grawhill 2001.
16. Valenzuela TD Criss EA Hammargren WM et al. Thermal stability of prehospital medications. Ann Emerg Med 1989 18 173 176.
17. Longland PW Trowbotham PC. Stability at room temperature of medicines normally recommended for cold storage. Pharmacogenomics J 1987 230 147 151.
18. Krohn M. Arzneimittelstabilität unter besonderen Einsatzbedingungen. Wehrmed Wehrpharm 1996 1 8 16.
19. Ahnefeld FW. Notfallkoffer - Nehmen Medikamente und Infusionslö sungen im Winter Schaden? Dtsch Med Wochenschr 1998 111 86.
20. Komatsu H Okada S Handa T. Suppressive effects of salts on droplet coalescence in a commercially available fat emulsion during freezing for storage. J Pharm Sci 1997 86 497 502.
21. Stricker H. Kapitel 4: Stabilität. In Bruchhausen F ed. Hagers Handbuch der pharmazeutischen Praxis. Berlin Springer Verlag 1991 1111 1118.
22. Moore K Thompson C Hayes R. Diabetes and extreme altitude mountaineering. Br J Sports Med 2001 35 83.
23. Hahnel J Lindner KH Ahnefeld FW. Endobronchial administration of emergency drugs. Resuscitation 1989 17 261 72.
24. Raehl CL. Endotracheal drug therapy in cardiopulmonary resuscitation. Clin Pharm 1986 5 572 579.
25. Zeisel U. Endobronchiale Medikamentenapplikation. Notfallmed 1994 20 484 491.
26. Mielke L Entholtner E Hargassner S et al. Medikamentengabe über den endobronchialen Zugang. Fortschr Med 1994 112 377 380.
27. June D. Die Umstellung ist vollzogen: Herausforderungen und Erfolge bei der Entwicklung FCKW-freier Dosieraerosole. Eur Respir Rev 1997 7 32 34.
28. Dittmann C. Untersuchungen über die Veränderung des Wirkstoffgehaltes in Adrekar-Ampullen unter präklinischen Lagerungsbedingungen In Klinik für Anaesthesiologie. Würzburg, Germany Bayrische Julius-Maximilians-Universität 1999 1 43.
29. Zeisel U Bauer M Tas P et al. Temperaturstabilität von Suprarenin bei verschiedenen Lagerungsbedingungen. Anaesthesie Intensivmed 1998 3 139 145.
30. Rothrock SG Green SM Schafermeyer RW Colucciello SA. Successful resuscitation from cardiac arrest using sublingual injection for medication delivery. Ann Emerg Med 1993 22 751 753.
31. Hasegawa E. The endotracheal use of emergency drugs. Pharmacol Crit Care 1986 15 60 63.
32. Cunningham FE Baughman VL Peters J Laurito CE. Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth 1994 6 430 433.
33. Gilkeson GS Delaney RL. Effectiveness of sublingual clonidine in patients unable to take oral medication. Drug Intell Clin Pharm 1987 21 262 263.
34. The 1998 European Resuscitation Council guidelines for adult advanced life support. Resuscitation 1998 37 81 90.
35. von Harten J Burggraaf K Danhof M et al. Negligible sublingual absorption of nifedipine. Lancet 1987 2 1363 1365.
36. Al-Waili NS Hasan NA. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine. Eur J Med Res 1999 4 193 198.
37. Fort S Lewis MJ Luscombe DK John DN. Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter. Br J Clin Pharmacol 1994 37 460 463.
38. John DN Fort S Lewis MJ Luscombe DK. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. Br J Clin Pharmacol 1992 33 623 627.
39. Asthana OP Woodcock BG Wenchel M et al. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration. Arzneimittelforschung 1984 34 498 502.
40. Woodcock BG Worner P Rietbrock N et al. Pharmakokinetik und Pharmakodynamik von Verapamil bei gesunden Versuchspersonen nach einmaliger oraler und sublingualer Applikation. Arzneimittelforschung 1982 32 1567 1571.
41. Incze A Frigy A Cotoi S. The efficacy of sublingual verapamil in controlling rapid ventricular rate in chronic atrial fibrillation. Rom J Intern Med 1998 36 219 225.
42. Desai DC Wagle DC Mohandas KM Swaroop VS. Dilatation of radiation-induced esophageal strictures under sublingual buprenorphine analgesia: a pilot study. Indian J Gastroenterol 1997 16 14 15.
43. Tolksdorf W Bangert J Glocke M Muller W. Sublingual buprenorphine in the therapy of postoperative pain. Anasth Intensivther Notfallmed 1984 19 117 123.
44. Grant IS Nimmo WS Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981 53 805 810.
45. Foesel T Hack C Knoll R et al. Intranasally administered midazolam in children: plasma concentrations and the effect of respiration. Anaesthesiology 1992 77.
46. Bunz R Gossler M. Intranasal premedication of young children using midazolam (Dormicum Clinical experience. Anasthesiol Intensivmed Notfallmed Schmerzther 1991 26 76 78.
47. Griffith N Howell S Mason DG. Intranasal midazolam for premedication of children undergoing day-case anaesthesia of two delivery systems with assessment of intra-observer variability. Br J Anaesth 1998 81 865 869.
48. Netzer N Hoefer M Steinacher J et al. Theophylline reduces periodic breathing during sleep at high altitude. In International Hypoxia Symposion 1999 Jasper, Canada.
49. The ICH tripartite guideline for stability testing of new drug substances and products (step 4 London European Agency for the Evaluation of Medical Products 1993.
50. Grimm W. International harmonization of stability tests for pharmaceuticals. The ICH tripartite guideline for stability testing of new drug substances and products. Eur J Pharm Biopharm 1995 41 194 195.
51. Schwab KO von Stockhausen HB. Plasma catecholamines after endotracheal administration of adrenaline during postnatal resuscitation. Arch Dis Child Fetal Neonatal Ed 1994 70 F213 F217.
52. Eigner WD. Hydroxyethylstärke - Molmassenbestimmung von Hydroxyethylstärke nach Temperaturbelastung. Krankenhauspharmazie 1988 9 20 22.
53. Mendelson J Jones RT. Assessing new pharmacotherapies for opiate dependence: buprenorphine and naloxone combinations in opiate-dependent volunteers. Clin Pharmacol Ther 1995 59 160.
54. Mendelson J Upton R Lin E et al. Sublingual buprenorphine and naloxone interactions in opiate-dependent patients stabilized on buprenorphine. Clin Pharmacol Ther 1997 61 191.
55. Mendelson J Jones RT Upton R Lin E. Dose-proportionality of sublingual buprenorphine and naloxone tablets. Clin Pharmacol Ther 1998 62 204.
56. Weinhold LL Preston KL Farre M. Buprenorphine alone and in combination with naloxone in nondependent humans. Drug Alcohol Depend 1992 30 263 274.
57. Tandberg D Abercrombie D. Treatment of heroin overdose with endotracheal naloxone. Ann Emerg Med 1982 11 443.